Since Donald Trump’s first term in office, US-China relations have steadily deteriorated. Coupled with the supply chain disruptions triggered by the Covid-19 pandemic, multinational companies have accelerated efforts to diversify risks—especially by reducing reliance on “Made in China” and Chinese supply chains.